Research & Development



  雲瑯選在這個地方修建營寨,眼光很好,一下子就把雷被居高臨下的軍事優勢給抵消掉了。 色色资源站无码AV网址 色一把-色一把伦理   長平想起來長門宮的路上,看到的熱鬧的勞作場面,不由自主的道︰“長門宮要比長安更有生氣。”   劉買冷笑一聲道︰“自尋死路!”色一把看片网站   “藏哪里?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo